Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000919574-16-012963
Filing Date
2016-05-13
Accepted
2016-05-13 17:10:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 d7146691_sc13d.htm SC 13D 105597
  Complete submission text file 0000919574-16-012963.txt   107140
Mailing Address C/O BROADWOOD CAPITAL INC. 724 FIFTH AVENUE, 9TH FLOOR NEW YORK NY 10019
Business Address C/O BROADWOOD CAPITAL INC. 724 FIFTH AVENUE, 9TH FLOOR NEW YORK NY 10019 212-508-5735
BROADWOOD PARTNERS LP (Filed by) CIK: 0001278386 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 6300 DUMBARTON CIRCLE FREMONT CA 94555
Business Address 6300 DUMBARTON CIRCLE FREMONT CA 94555 510-456-3805
Asterias Biotherapeutics, Inc. (Subject) CIK: 0001572552 (see all company filings)

EIN.: 461047971 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-87639 | Film No.: 161649434
SIC: 2836 Biological Products, (No Diagnostic Substances)